KNCV Tuberculosis Foundation
KNCV Tuberculosis Foundation is a 120-year-old Dutch non-profit foundation dedicated to eliminating tuberculosis, providing free TB education, advocacy, peer support, professional training, and innovative diagnostics to Dutch patients, healthcare professionals, and government health partners.
- Company typePrivate
- Founded1903
- HeadquartersDen Haag, Netherlands
- Headcount51–100
- GTM typeB2B and B2C
- OfferingServices
What KNCV Tuberculosis Foundation does
KNCV Tuberculosis Foundation (legally: KNCV Tuberculosefonds) is a Dutch non-profit foundation established in 1903 and headquartered in Den Haag, Netherlands, with 51-100 employees. The organization is dedicated to eliminating tuberculosis, supporting TB control efforts in the Netherlands and increasingly internationally through its kncvtbplus.com platform. Its mission addresses TB as the world's deadliest infectious disease, citing 1.3 million annual deaths and nearly 600 daily child deaths globally.
The foundation's product and program portfolio is mission-driven rather than commercial. Core programs include the Patiënten voor Patiënten peer support initiative, the ASCENT digital technology project supporting patients through treatment, an innovative stool-based pediatric TB diagnostic test, and the "Nooit meer een pandemie" all-in-one infectious disease diagnostic initiative. Supporting add-on services include the Kennisbank voor Professionals (a knowledge bank for clinicians), continuing education programs (bij- en nascholing), research collaboration with Dutch universities, and direct patient support services. Underlying components involve digital health technologies and diagnostic innovations, although no specific AI/ML capability is disclosed.
Commercially, KNCV operates as a donation-funded charity: all services to patients and healthcare professionals are provided free of charge, and the organization is financed through individual donations (one-time and recurring monthly via secure.tuberculose.nl), bequests and legacy gifts, and event-based fundraising such as the Eiger Ultra Trail. Go-to-market is community-led: the foundation reaches healthcare professionals and patients through deep institutional partnerships with GGD'en (municipal health services), RIVM CIb (Centre for Infectious Disease Control), professional medical associations (NVALT, NVMM, NVHB, NVK, V&VN, MTM BeVe), Dutch universities, and emerging patient organizations. Marketing is multi-channel, centered on the "Tering!" awareness campaign, patient storytelling (Dwalen in Verhalen), website content on tuberculose.nl, and physician-ambassador led events.
KNCV Tuberculosis Foundation firmographics
Firmographics- Name
- KNCV Tuberculosis Foundation
- Legal name
- KNCV Tuberculosefonds
- Website
- https://kncvtbc.org
- Company type
- Private
- Founded year
- 1903
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- KNCV Tuberculosis Foundation is a 120-year-old Dutch non-profit foundation dedicated to eliminating tuberculosis, providing free TB education, advocacy, peer support, professional training, and innovative diagnostics to Dutch patients, healthcare professionals, and government health partners.
- Ownership category
- akta.pro rank
KNCV Tuberculosis Foundation industry classification
Industry- Product category
- Public Health Non-Profit Services
- NAICS
- Voluntary Health Organizations (813212), Social Advocacy Organizations (8133)
- SIC
- Services-Misc Health & Allied Services, Nec (8090), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Disease-Specific Global Programs (HIV/TB/Malaria/NTDs) (HLAJAKAF)
- akta.pro secondary industries
- Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN), Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)
Keywords
Where KNCV Tuberculosis Foundation is headquartered
LocationHeadquarters
- HQ city
- Den Haag
- HQ country
- Netherlands
- HQ region
- Europe
Markets served
KNCV Tuberculosis Foundation business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Individual Donations: One-time and recurring donations from individuals supporting TB elimination efforts in the Netherlands and globally. Monthly giving programs (structureel doneren) and single donations (eenmalig doneren) are accepted through the organization's secure donation portal.
- Bequests and Legacy Giving: The organization accepts bequests and legacy gifts, allowing supporters to include KNCV in their testament (nalaten/testament).
Go-to-market motion1 record
Distribution channels5 records
Marketing channels9 records
KNCV Tuberculosis Foundation product offering
Product offeringCore offering
KNCV Tuberculosis Foundation (KNCV Tuberculosefonds) is a Dutch non-profit foundation that provides evidence-based technical assistance, policy development, advocacy, and patient support services focused on tuberculosis (TB) elimination. It delivers mission-driven programs including peer patient support (Patiënten voor Patiënten), innovative pediatric TB diagnostics (stool test), digital treatment adherence tools (ASCENT project), professional knowledge resources, continuing medical education, and TB research support in partnership with Dutch municipal health services, RIVM, and professional medical associations.
Product overview
KNCV Tuberculosefonds operates as a disease intervention and public health organization rather than a traditional software product company. The organization's portfolio consists of mission-driven TB elimination initiatives including patient support programs (Patiënten voor Patiënten), innovative diagnostic solutions (the stool test for children, all-in-one infectious disease test), and digital health interventions (ASCENT project). These are complemented by professional knowledge resources including a knowledge bank, continuing education, research support, and patient support services. The offerings function as integrated public health programs rather than a unified software platform.
Differentiator
Problem solved
Functional benefit
Products and services
- Patiënten voor Patiënten (Patients for Patients) A peer support program connecting tuberculosis patients with others who have lived experience with TBC, providing mutual support and guidance throughout treatment.
- Nooit meer een pandemie (No More Pandemics) - All-in-One Infectious Disease Test An all-in-one test initiative for detecting all infectious diseases, aiming to prevent future pandemics through comprehensive diagnostic capabilities.
- Stool Test for Pediatric TB Diagnosis A child-friendly diagnostic tool using stool samples for rapid and painless tuberculosis detection in children, eliminating the need for invasive procedures.
- ASCENT Project - Digital TB Patient Support A digital technology initiative that innovatively applies digital tools to support TB patients throughout their treatment journey, improving adherence and outcomes.
- Bij- en nascholing (Continuing Medical Education) Professional training and continuing education programs for healthcare workers on tuberculosis prevention, diagnosis, and treatment protocols.
- Onderzoek (TB Research Support) Research support and collaboration programs advancing tuberculosis science, treatment methods, and public health interventions.
Quantifiable outcome
- Nearly 1.3 million lives lost to TB annually worldwide - KNCV's mission is to eliminate these unnecessary deaths through prevention and treatment
Companies that use KNCV Tuberculosis Foundation
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles4 records
KNCV Tuberculosis Foundation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
KNCV Tuberculosis Foundation partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- GGD'en (Dutch Municipal Health Services)coreKNCV collaborates with GGD'en (municipal health services) across the Netherlands to support TB control, screening, contact tracing, and treatment monitoring throughout the country.
- RIVM CIb (Centre for Infectious Disease Control)corePartnership with RIVM's Centre for Infectious Disease Control (CIb) for national TB surveillance, outbreak response coordination, and infectious disease policy alignment.
- NVALT (Dutch Association of Physicians for Lung Diseases and Tuberculosis)coreCollaboration with the Dutch Association of Physicians for Lung Diseases and Tuberculosis to develop treatment guidelines, professional education, and quality standards for TB care.
- NVMM (Dutch Association of Medical Microbiology)corePartnership with the Dutch Association of Medical Microbiology to advance TB diagnostics, laboratory standards, and microbiological testing protocols.
- NVHB (Dutch Association of Internal Medicine)minorCollaboration with the Dutch Association of Internal Medicine for TB-related medical education and treatment protocols for internal medicine contexts.
- NVK (Dutch Pediatric Association)corePartnership with the Dutch Pediatric Association to address pediatric TB diagnosis challenges, including the development of stool-based testing for children.
- V&VN (Dutch Association of Nurses and Care Professionals)coreCollaboration with the Dutch Association of Nurses and Care Professionals to support TB patient care, nursing protocols, and community health worker training.
- MTM BeVeminorProfessional organization partnership for TB-related professional standards and medical training support.
- Dutch UniversitiescoreAcademic partnerships with universities for TB research, clinical trials, epidemiological studies, and knowledge development in tuberculosis science.
- Tuberculosis Patients and Patient OrganizationscoreCentral partnership with TB patients and emerging patient organizations (including support for establishing a patient organization for tuberculosis in the Netherlands) to ensure patient-centered approaches to TB care.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
KNCV Tuberculosis Foundation competitors and assessment
Company assessmentDirect peers
- Stop TB Partnership: UN-hosted global partnership dedicated exclusively to TB elimination, coordinating international TB actors. Directly comparable to KNCV's global TB mission and serves a similar advocacy and technical assistance role at larger scale.
- Results: Advocacy non-profit focused on ending TB, poverty, and hunger through citizen advocacy and policy change. Comparable non-profit advocacy and donor-driven engagement model around TB.
- Partners in Health: Non-profit delivering health services to the poor globally with major TB programs (e.g., in Peru, Haiti, Rwanda). Directly comparable as a mission-driven non-profit working on TB care delivery and treatment support.
- KNCV TB Plus: The international arm/platform of KNCV Tuberculosis Foundation itself; included to reflect how the organization itself structures its global-facing activity relative to its domestic operations.
- TB Alliance (Global Alliance for TB Drug Development): Non-profit product development partnership focused on developing and delivering new TB regimens. Comparable mission alignment on TB innovation and access, with a similar non-profit operating model.
Broad incumbents
- American Lung Association: Long-standing US voluntary health organization with historical TB mission expanded to broader lung disease. Comparable operating model as a 100+ year-old voluntary health charity with research, advocacy, and education programs.
- Médecins Sans Frontières (MSF): International medical humanitarian organization with significant TB treatment programs in low-resource settings. Comparable as a non-profit delivering TB care and patient support, though broader in scope.
- The Global Fund to Fight AIDS, Tuberculosis and Malaria: Massive multilateral financing mechanism that includes TB among its three priority diseases. Directly overlaps with KNCV's TB mission area and represents both a peer and a potential institutional funder.
- Unitaid: Global health financing partnership that invests in innovations to address HIV, TB, and malaria. Operates in adjacent TB diagnostic and treatment innovation space where KNCV's ASCENT and stool-test initiatives also play.
Emerging players
- Treatment Action Group (TAG): Independent activist and community-based research organization working on TB and HIV. Comparable as a non-profit doing TB research, policy, and advocacy, but with a narrower advocacy/research focus versus KNCV's broader program mix.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
KNCV Tuberculosis Foundation social profiles
Digital presenceKNCV Tuberculosis Foundation financial estimates
Financial estimateRevenue estimate
Valuation estimate
KNCV Tuberculosis Foundation leadership team
Management profileNumber of profiles
KNCV Tuberculosis Foundation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KNCV Tuberculosis Foundation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KNCV Tuberculosis Foundation
What does KNCV Tuberculosis Foundation do?
KNCV Tuberculosis Foundation (KNCV Tuberculosefonds) is a Dutch non-profit foundation that provides evidence-based technical assistance, policy development, advocacy, and patient support services focused on tuberculosis (TB) elimination. It delivers mission-driven programs including peer patient support (Patiënten voor Patiënten), innovative pediatric TB diagnostics (stool test), digital treatment adherence tools (ASCENT project), professional knowledge resources, continuing medical education, and TB research support in partnership with Dutch municipal health services, RIVM, and professional medical associations.
Is KNCV Tuberculosis Foundation a public or private company?
KNCV Tuberculosis Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was KNCV Tuberculosis Foundation founded?
KNCV Tuberculosis Foundation was founded in 1903. It employs 51 to 100 people.
Where is KNCV Tuberculosis Foundation based?
KNCV Tuberculosis Foundation is headquartered in Den Haag, Netherlands, in the Europe region.
How does KNCV Tuberculosis Foundation make money?
Two revenue lines are on record. Individual Donations are the primary driver. The others are bequests and Legacy Giving.
Who are KNCV Tuberculosis Foundation's main competitors?
Direct peers on record are Stop TB Partnership, Results, Partners in Health, KNCV TB Plus and TB Alliance (Global Alliance for TB Drug Development). Broad incumbents are American Lung Association, Médecins Sans Frontières (MSF), The Global Fund to Fight AIDS, Tuberculosis and Malaria and Unitaid. Treatment Action Group (TAG) is listed as an emerging player.
Does KNCV Tuberculosis Foundation have an API?
No public API is recorded for KNCV Tuberculosis Foundation.
What industry is KNCV Tuberculosis Foundation in?
KNCV Tuberculosis Foundation's product category is Public Health Non-Profit Services. Its primary akta.pro industry code is HLAJAKAF, Disease-Specific Global Programs (HIV/TB/Malaria/NTDs), with a secondary code of HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations. Its NAICS code is 813212 and its SIC code is 8090.